- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cows' milk protein enteropathy;Severe cows' milk protein enteropathy with failure to thrive;Combined intolerance to cows' milk protein, soy protein and protein hydrolysate formulae;Cows' milk anaphylaxis;Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and soy protein;Severe intestinal malabsorption including short bowel syndrome;Eosinophilic oesophagitis.
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 497KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 66KB)
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids, medium chain triglycerides and 2- fucosyllactose and lacto-n-neotetraose – November 2022
Amino Acid Synthetic Formula Supplemented with Long Chain Polyunsaturated Fatty Acids, Medium Chain Triglycerides, 2’- Fucosyllactose and Lacto-N-Neotetraose: Oral powder 400 g; Alfamino®
Last updated
3 March 2023